Antiatherosclerotic potential of clopidogrel: Antioxidant and anti-inflammatory approaches

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Hadi, Najah R ^a   Mohammad, Bassim I ^b   Ajeena, Ihsan M ^a   Sahib, Hussam H ^a  

^a UNIVERSITY OF KUFA   (Iraq)

^b UNIVERSITY OF AL QADISIYAH   (Iraq)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CLOPIDOGREL; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 17; MALONALDEHYDE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; DRUG DERIVATIVE; MONOCYTE CHEMOTACTIC PROTEIN 1; TICLOPIDINE;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROGENIC DIET; CONTROLLED STUDY; DOMESTIC RABBIT; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; ATHEROSCLEROSIS; BIOSYNTHESIS; DRUG EFFECT; GENE EXPRESSION REGULATION; HUMAN; PATHOLOGY; RABBIT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; ATHEROSCLEROSIS; CHEMOKINE CCL2; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-17; RABBITS; TICLOPIDINE; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84896085615     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/790263     Document Type: Article

References (28)

1. Anderson T. J., Assessment and treatment of endothelial dysfunction in humans. Journal of the American College of Cardiology 1999 34 3 631 638 (Pubitemid 29436165)
2. Pyorala K., Laakso M., Uusitupa M., Diabetes and atherosclerosis: an epidemiologic view. Diabetes/Metabolism Reviews 1987 3 2 463 524 2-s2.0-0023090431 (Pubitemid 17050766)
3. Fan J., Watanabe T., Inflammatory reactions in the pathogenesis of atherosclerosis. Journal of Atherosclerosis and Thrombosis 2003 10 2 63 71 2-s2.0-0042510743
4. Packard R. R. S., Libby P., Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clinical Chemistry 2008 54 1 24 38 2-s2.0-38749112555 10.1373/clinchem.2007.097360 (Pubitemid 351182593)
5. Li H., Cybulsky M. I., Gimbrone M. A. Jr., Libby P., An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arteriosclerosis and Thrombosis 1993 13 2 197 204 2-s2.0-0027476229 (Pubitemid 23056792)
6. Libby P., Inflammation in atherosclerosis. Nature 2002 420 6917 868 874 2-s2.0-0037180771 10.1038/nature01323 (Pubitemid 36019640)
7. Clinton S. K., Underwood R., Hayes L., Sherman M. L., Kufe D. W., Libby P., Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. The American Journal of Pathology 1992 140 2 301 316 2-s2.0-0026536343
8. Davì G., Patrono C., Platelet activation and atherothrombosis. The New England Journal of Medicine 2007 357 2482 2494
9. Cayman C., Product information, clopidogrel. http://www.caymanchem.com/
10. Herbert J.-M., Dol F., Bernat A., Falotico R., Lalé A., Savi P., The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit. Thrombosis and Haemostasis 1998 80 3 512 518 2-s2.0-0031727053 (Pubitemid 28438751)
11. Sasani M., Yazgan B., Celebi I., Hypercholesterolemia increases vasospasm resulting from basilar artery subarachnoid hemorrhage in rabbits which is attenuated by Vitamin. Surgical Neurology International 2011 14 2 29
12. Daugherty A., Zweifel B. S., Schonfeld G., Probucol attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits. British Journal of Pharmacology 1989 98 2 612 618 2-s2.0-0024461584 (Pubitemid 19245770)
13. Hayashi T., Fukuto J. M., Ignarro L. J., Chaudhuri G., Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proceedings of the National Academy of Sciences of the United States of America 1992 89 23 11259 11263 2-s2.0-0026437582 10.1073/pnas.89.23.11259
14. Beutler E., Duron O., Kelly B. M., Improved method for the determination of blood glutathione. The Journal of Laboratory and Clinical Medicine 1963 61 882 888 2-s2.0-73649194769
15. Mumford S. L., Labrotory Procedure Manual 2004 2nd Washington, DC, USA USFWS, Olympia Fish Health Center
16. Chen Y.-H., Lin S.-J., Chen J.-W., Ku H.-H., Chen Y.-L., Magnolol attenuates VCAM-1 expression in vitro in TNF- α-treated human aortic endothelial cells and in vivo in the aorta of cholesterol-fed rabbits. British Journal of Pharmacology 2002 135 1 37 47 2-s2.0-0036157197 (Pubitemid 34102096)
17. Gu Q., Chen J.-L., Ruan Y.-M., Inhibitory effects of aspirin, clopidogrel, and their combination on the progression of atherosclerosis in rabbits. Chinese Medical Journal 2005 27 1 87 91 2-s2.0-33744998391
18. Srinivas M., Annapurna A., Reddy Y. N., Anti-atherosclerotic effect of atorvastatin and clopidogrel alone and in combination in rats. Indian Journal of Experimental Biology 2008 46 10 698 703 2-s2.0-58149373989
19. Heitzer T., Rudolph V., Schwedhelm E., Karstens M., Sydow K., Ortak M., Tschentscher P., Meinertz T., Böger R., Baldus S., Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: evidence for antioxidant and antiinflammatory effects. Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 7 1648 1652 2-s2.0-33745960097 10.1161/01.ATV.0000225288.74170.dc (Pubitemid 44288996)
20. Steinhubl S. R., Badimon J. J., Bhatt D. L., Herbert J.-M., Lüscher T., Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease. Vascular Medicine 2007 12 2 113 122 2-s2.0-34347204130 10.1177/1358863X07077462 (Pubitemid 46995474)
21. Li M., Zhang Y., Ren H., Zhang Y., Zhu X., Effect of clopidogrel on the inflammatory progression of early atherosclerosis in rabbits model. Atherosclerosis 2007 194 2 348 356 2-s2.0-34848877719 10.1016/j.atherosclerosis. 2006.11.006 (Pubitemid 47513098)
22. Evangelista V., Manarini S., Dell'Elba G., Martelli N., Napoleone E., di Santo A., Savi P., Lorenzet R., Clopidogrel inhibits platelet-leukocyte adhesion and platelet-dependent leukocyte activation. Thrombosis and Haemostasis 2005 94 3 568 577 2-s2.0-24944457299 10.1160/TH05-01-0020 (Pubitemid 41300854)
23. Ren H., Li M., Feng L., Jiang J., Zhang Y., Zhang Y., Zhu X., Effects of clopidogrel on vascular proliferation and apoptosis in an atherosclerotic rabbit model. Journal of Cardiovascular Pharmacology 2010 55 6 617 624 2-s2.0-77953808363 10.1097/FJC.0b013e3181dc98dc
24. Taleb S., Romain M., Ramkhelawon B., Uyttenhove C., Pasterkamp G., Herbin O., Esposito B., Perez N., Yasukawa H., Van Snick J., Yoshimura A., Tedgui A., Mallat Z., Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. Journal of Experimental Medicine 2009 206 10 2067 2077 2-s2.0-70350433833 10.1084/jem.20090545
25. Smith E., Prasad K.-M. R., Butcher M., Dobrian A., Kolls J. K., Ley K., Galkina E., Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice. Circulation 2010 121 15 1746 1755 2-s2.0-77951485998 10.1161/CIRCULATIONAHA.109.924886
26. Pietrowski E., Bender B., Huppert J., White R., Luhmann H. J., Kuhlmann C. R. W., Pro-inflammatory effects of interleukin-17A on vascular smooth muscle cells involve NAD(P)H-oxidase derived reactive oxygen species. Journal of Vascular Research 2011 48 1 52 58 2-s2.0-77954202847 10.1159/000317400
27. Shiomi M., Ito T., The Watanabe heritable hyperlipidemic (WHHL) rabbit, its characteristics and history of development: a tribute to the late Dr. Yoshio Watanabe. Atherosclerosis 2009 207 1 1 7 2-s2.0-70350573441 10.1016/j.atherosclerosis.2009.03.024
28. Korosoglou G., Weiss R. G., Kedziorek D. A., Walczak P., Gilson W. D., Schär M., Sosnovik D. E., Kraitchman D. L., Boston R. C., Bulte J. W. M., Weissleder R., Stuber M., Noninvasive detection of macrophage-rich atherosclerotic plaque in hyperlipidemic rabbits using "positive contrast" magnetic resonance imaging. Journal of the American College of Cardiology 2008 52 6 483 491 2-s2.0-47949124259 10.1016/j.jacc.2008.03.063 (Pubitemid 352043838)